Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2005-02

AUTHORS

E Giovannetti, F Basolo, M Del Tacca, M Deri, R Danesi, S Barachini, V Mey

ABSTRACT

The pyrimidine analogue gemcitabine is an established effective agent in the treatment of non-small-cell lung cancer (NSCLC). The present study investigates whether gemcitabine would be synergistic with the topoisomerase I inhibitor topotecan against the NSCLC A549 and Calu-6 cells. Cells were treated with gemcitabine and topotecan for 1 h and the type of drug interaction was assessed using the combination index (CI). Cell cycle alterations were analysed by flow cytometry, while apoptosis was examined by the occurrence of DNA internucleosomal fragmentation, nuclear condensation and caspase-3 activation. Moreover, the possible involvement of the PI3K-Akt signalling pathway was investigated by the measurement of Akt phosphorylation. Finally, quantitative, real-time PCR (QRT-PCR) was used to study modulation of the gemcitabine-activating enzyme deoxycytidine kinase (dCK) and the cellular target enzyme ribonucleotide reductase (RR). In results, it was found that simultaneous and sequential topotecan --> gemcitabine treatments were synergistic, while the reverse sequence was antagonistic in both cell lines. DNA fragmentation, nuclear condensation and enhanced caspase-3 activity demonstrated that the drug combination markedly increased apoptosis in comparison with either single agent, while cell cycle analysis showed that topotecan increased cells in S phase. Furthermore, topotecan treatment significantly decreased the amount of the activated form of Akt, and enhanced the expression of dCK (+155.0 and +115.3% in A549 and Calu-6 cells, respectively), potentially facilitating gemcitabine activity. In conclusion, these results indicate that the combination of gemcitabine and topotecan displays schedule-dependent activity in vitro against NSCLC cells. The gemcitabine --> topotecan sequence is antagonistic while drug synergism is obtained with the simultaneous and the sequential topotecan --> gemcitabine combinations, which are associated with induction of decreased Akt phosphorylation and increased dCK expression. More... »

PAGES

681

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382

DOI

http://dx.doi.org/10.1038/sj.bjc.6602382

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042132505

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15700043


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspase 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Fragmentation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine Kinase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Enzymologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Serine-Threonine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-akt", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Topoisomerase I Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Topotecan", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giovannetti", 
        "givenName": "E", 
        "id": "sg:person.0577505063.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577505063.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pathological Anatomy and Histology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Basolo", 
        "givenName": "F", 
        "id": "sg:person.01043347623.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043347623.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Del Tacca", 
        "givenName": "M", 
        "id": "sg:person.0101712630.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0101712630.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Deri", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Danesi", 
        "givenName": "R", 
        "id": "sg:person.0704167507.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704167507.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barachini", 
        "givenName": "S", 
        "id": "sg:person.01324114222.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324114222.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mey", 
        "givenName": "V", 
        "id": "sg:person.01003441425.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003441425.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s002800000183", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000135772", 
          "https://doi.org/10.1007/s002800000183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004051184", 
          "https://doi.org/10.1038/sj.bjc.6690452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004051184", 
          "https://doi.org/10.1038/sj.bjc.6690452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/86.20.1517", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007437694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-199754030-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011803547", 
          "https://doi.org/10.2165/00003495-199754030-00009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000011923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013350898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.10806", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014472277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.10166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015732358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.274.7.4335", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016160331"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(03)90522-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016902652"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0215(20000515)86:4<570::aid-ijc20>3.0.co;2-t", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018134417"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa031644", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018253348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(02)00502-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018310648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(02)00502-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018310648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-2952(98)00318-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018647627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0092-8674(00)81005-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021076197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-03-3363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022118795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006325929424", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022329366", 
          "https://doi.org/10.1023/a:1006325929424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-2952(98)00316-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028767356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800000273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031302839", 
          "https://doi.org/10.1007/s002800000273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(98)00425-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032352964"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(99)00223-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035253746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-03-0520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036865675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-120022363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037383721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1368-7646(02)00002-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039632637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4400336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042512023", 
          "https://doi.org/10.1038/sj.cdd.4400336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4400336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042512023", 
          "https://doi.org/10.1038/sj.cdd.4400336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-4165(99)00209-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045475119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/88.11.734", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046560733"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(03)00136-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052265808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(03)00136-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052265808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi9729357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055215192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi9729357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055215192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.311.7010.899", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062773493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.311.7010.899", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062773493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074273055", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074520995", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074708162", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074712924", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074778809", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074859791", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3727/096504001108747819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074951474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075104035", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082401402", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082893566", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083077109", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083077109", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajhp/54.2.162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083077109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajhp/54.2.162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083077109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajhp/54.2.162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083077109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083269732", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083347691", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-02", 
    "datePublishedReg": "2005-02-01", 
    "description": "The pyrimidine analogue gemcitabine is an established effective agent in the treatment of non-small-cell lung cancer (NSCLC). The present study investigates whether gemcitabine would be synergistic with the topoisomerase I inhibitor topotecan against the NSCLC A549 and Calu-6 cells. Cells were treated with gemcitabine and topotecan for 1 h and the type of drug interaction was assessed using the combination index (CI). Cell cycle alterations were analysed by flow cytometry, while apoptosis was examined by the occurrence of DNA internucleosomal fragmentation, nuclear condensation and caspase-3 activation. Moreover, the possible involvement of the PI3K-Akt signalling pathway was investigated by the measurement of Akt phosphorylation. Finally, quantitative, real-time PCR (QRT-PCR) was used to study modulation of the gemcitabine-activating enzyme deoxycytidine kinase (dCK) and the cellular target enzyme ribonucleotide reductase (RR). In results, it was found that simultaneous and sequential topotecan --> gemcitabine treatments were synergistic, while the reverse sequence was antagonistic in both cell lines. DNA fragmentation, nuclear condensation and enhanced caspase-3 activity demonstrated that the drug combination markedly increased apoptosis in comparison with either single agent, while cell cycle analysis showed that topotecan increased cells in S phase. Furthermore, topotecan treatment significantly decreased the amount of the activated form of Akt, and enhanced the expression of dCK (+155.0 and +115.3% in A549 and Calu-6 cells, respectively), potentially facilitating gemcitabine activity. In conclusion, these results indicate that the combination of gemcitabine and topotecan displays schedule-dependent activity in vitro against NSCLC cells. The gemcitabine --> topotecan sequence is antagonistic while drug synergism is obtained with the simultaneous and the sequential topotecan --> gemcitabine combinations, which are associated with induction of decreased Akt phosphorylation and increased dCK expression.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6602382", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "92"
      }
    ], 
    "name": "Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile", 
    "pagination": "681", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c8b2a0633725f3a8e00edd3d1d149046fa818c82961f5a97907499e0e70f1e55"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15700043"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6602382"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042132505"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6602382", 
      "https://app.dimensions.ai/details/publication/pub.1042132505"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29216_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/6602382"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602382'


 

This table displays all metadata directly associated to this object as RDF triples.

330 TRIPLES      21 PREDICATES      96 URIs      45 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6602382 schema:about N21b5a8d4c3d7432ca03c6cdf6be2e726
2 N2ccff8f39441407a91d0265aef1c5315
3 N44402c099f3342718e86d95d4d134003
4 N498d335f56ae4ac3a5638e030f7ac33a
5 N55790c8b260040c4872a17381300fcb9
6 N5af7cf9d3a65452496d04e1ea9cec674
7 N5df7c105da2a4c34a75c4b9935884d52
8 N66a37d9ae6194e4992813c8b1d9119dc
9 N719cf776d6e04579aa97f6c57f49a7d5
10 N81e20b57e297448eb71663e10db58042
11 N8aee7fa99ffa47d48a418583f61103cf
12 Nb1f05a7eaf024ba0a27f709c72e20f98
13 Nb4d0fa1874614ee59dd9a9266a3cf12b
14 Nbd9af92e45a744a89094e99375fde543
15 Nbf0b162e14684dfb8c6cd30a4658b628
16 Nc42a8558346c4a5899e77c1f88466f8b
17 Nce632787b0c946c2ba4bda821ef101ec
18 Nd1ae83b105d14778bb8c40f482ce67aa
19 Nd8c53ae8a9d54dac8862ac9d9ce19c21
20 Nda7f3b5a5c9043cb94d56f9675125750
21 Ndc9dc392eae24dcba1ced67daf2ca347
22 Ne2c11a5c98494926b5863e4e808e7616
23 Ne65e3704e08e4beca6cdb681d2f1eb9e
24 Necd3324682c9475e944149cd7196e5a6
25 anzsrc-for:06
26 anzsrc-for:0601
27 schema:author N2fcdd4296fb14a898e6974948a4123a8
28 schema:citation sg:pub.10.1007/s002800000183
29 sg:pub.10.1007/s002800000273
30 sg:pub.10.1023/a:1006325929424
31 sg:pub.10.1038/sj.bjc.6690452
32 sg:pub.10.1038/sj.cdd.4400336
33 sg:pub.10.2165/00003495-199754030-00009
34 https://app.dimensions.ai/details/publication/pub.1074273055
35 https://app.dimensions.ai/details/publication/pub.1074520995
36 https://app.dimensions.ai/details/publication/pub.1074708162
37 https://app.dimensions.ai/details/publication/pub.1074712924
38 https://app.dimensions.ai/details/publication/pub.1074778809
39 https://app.dimensions.ai/details/publication/pub.1074859791
40 https://app.dimensions.ai/details/publication/pub.1075104035
41 https://app.dimensions.ai/details/publication/pub.1082401402
42 https://app.dimensions.ai/details/publication/pub.1082893566
43 https://app.dimensions.ai/details/publication/pub.1083077109
44 https://app.dimensions.ai/details/publication/pub.1083269732
45 https://app.dimensions.ai/details/publication/pub.1083347691
46 https://doi.org/10.1002/(sici)1097-0215(20000515)86:4<570::aid-ijc20>3.0.co;2-t
47 https://doi.org/10.1002/cncr.10806
48 https://doi.org/10.1002/ijc.10166
49 https://doi.org/10.1016/s0006-2952(98)00316-5
50 https://doi.org/10.1016/s0006-2952(98)00318-9
51 https://doi.org/10.1016/s0092-8674(00)81005-3
52 https://doi.org/10.1016/s0169-5002(02)00502-0
53 https://doi.org/10.1016/s0169-5002(03)00136-3
54 https://doi.org/10.1016/s0169-5002(03)90522-8
55 https://doi.org/10.1016/s0304-4165(99)00209-3
56 https://doi.org/10.1016/s0959-8049(98)00425-0
57 https://doi.org/10.1016/s0959-8049(99)00223-3
58 https://doi.org/10.1016/s1368-7646(02)00002-x
59 https://doi.org/10.1021/bi9729357
60 https://doi.org/10.1056/nejmoa031644
61 https://doi.org/10.1074/jbc.274.7.4335
62 https://doi.org/10.1081/cnv-120022363
63 https://doi.org/10.1093/ajhp/54.2.162
64 https://doi.org/10.1093/jnci/86.20.1517
65 https://doi.org/10.1093/jnci/88.11.734
66 https://doi.org/10.1136/bmj.311.7010.899
67 https://doi.org/10.1158/0008-5472.can-03-3363
68 https://doi.org/10.1158/1078-0432.ccr-03-0520
69 https://doi.org/10.1159/000011923
70 https://doi.org/10.3727/096504001108747819
71 schema:datePublished 2005-02
72 schema:datePublishedReg 2005-02-01
73 schema:description The pyrimidine analogue gemcitabine is an established effective agent in the treatment of non-small-cell lung cancer (NSCLC). The present study investigates whether gemcitabine would be synergistic with the topoisomerase I inhibitor topotecan against the NSCLC A549 and Calu-6 cells. Cells were treated with gemcitabine and topotecan for 1 h and the type of drug interaction was assessed using the combination index (CI). Cell cycle alterations were analysed by flow cytometry, while apoptosis was examined by the occurrence of DNA internucleosomal fragmentation, nuclear condensation and caspase-3 activation. Moreover, the possible involvement of the PI3K-Akt signalling pathway was investigated by the measurement of Akt phosphorylation. Finally, quantitative, real-time PCR (QRT-PCR) was used to study modulation of the gemcitabine-activating enzyme deoxycytidine kinase (dCK) and the cellular target enzyme ribonucleotide reductase (RR). In results, it was found that simultaneous and sequential topotecan --> gemcitabine treatments were synergistic, while the reverse sequence was antagonistic in both cell lines. DNA fragmentation, nuclear condensation and enhanced caspase-3 activity demonstrated that the drug combination markedly increased apoptosis in comparison with either single agent, while cell cycle analysis showed that topotecan increased cells in S phase. Furthermore, topotecan treatment significantly decreased the amount of the activated form of Akt, and enhanced the expression of dCK (+155.0 and +115.3% in A549 and Calu-6 cells, respectively), potentially facilitating gemcitabine activity. In conclusion, these results indicate that the combination of gemcitabine and topotecan displays schedule-dependent activity in vitro against NSCLC cells. The gemcitabine --> topotecan sequence is antagonistic while drug synergism is obtained with the simultaneous and the sequential topotecan --> gemcitabine combinations, which are associated with induction of decreased Akt phosphorylation and increased dCK expression.
74 schema:genre research_article
75 schema:inLanguage en
76 schema:isAccessibleForFree true
77 schema:isPartOf N53898db40bbb4c80989e887d028c7ec1
78 N7f898e8d80c144e691fc56b4bf45284b
79 sg:journal.1017082
80 schema:name Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile
81 schema:pagination 681
82 schema:productId N107254a2bbe14e0a840099fc5ec42567
83 N740d0f752142419cadcf953f08076a76
84 N87406a1519a24e8a82df562635fe8374
85 Naafbfee2b9f345c4b9e30e66a6a42918
86 Nd4d526f6cd4c4c1e9177f5a1451b1ee7
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042132505
88 https://doi.org/10.1038/sj.bjc.6602382
89 schema:sdDatePublished 2019-04-11T11:56
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher N0af0151f9cde4c6db1433883f0f38bb4
92 schema:url https://www.nature.com/articles/6602382
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N098cb3d34d314221a0f5b55d411761ef rdf:first sg:person.01043347623.83
97 rdf:rest Na88855a4b29b467496266ab69e75af83
98 N0af0151f9cde4c6db1433883f0f38bb4 schema:name Springer Nature - SN SciGraph project
99 rdf:type schema:Organization
100 N107254a2bbe14e0a840099fc5ec42567 schema:name doi
101 schema:value 10.1038/sj.bjc.6602382
102 rdf:type schema:PropertyValue
103 N12aca037f36940f7bca60fac62958494 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
104 schema:familyName Deri
105 schema:givenName M
106 rdf:type schema:Person
107 N21b5a8d4c3d7432ca03c6cdf6be2e726 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Drug Synergism
109 rdf:type schema:DefinedTerm
110 N2ccff8f39441407a91d0265aef1c5315 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Gene Expression Regulation, Enzymologic
112 rdf:type schema:DefinedTerm
113 N2fcdd4296fb14a898e6974948a4123a8 rdf:first sg:person.0577505063.56
114 rdf:rest N098cb3d34d314221a0f5b55d411761ef
115 N41fd9683d0ba44cfb659116db6604fc6 rdf:first sg:person.0704167507.01
116 rdf:rest Na2f3197a31074d8ab869a3e6e795118d
117 N44402c099f3342718e86d95d4d134003 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Caspases
119 rdf:type schema:DefinedTerm
120 N498d335f56ae4ac3a5638e030f7ac33a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Antimetabolites, Antineoplastic
122 rdf:type schema:DefinedTerm
123 N53898db40bbb4c80989e887d028c7ec1 schema:issueNumber 4
124 rdf:type schema:PublicationIssue
125 N5512702fc7004465a1bb3485f3448724 rdf:first N12aca037f36940f7bca60fac62958494
126 rdf:rest N41fd9683d0ba44cfb659116db6604fc6
127 N55790c8b260040c4872a17381300fcb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Polymerase Chain Reaction
129 rdf:type schema:DefinedTerm
130 N5af7cf9d3a65452496d04e1ea9cec674 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Carcinoma, Non-Small-Cell Lung
132 rdf:type schema:DefinedTerm
133 N5df7c105da2a4c34a75c4b9935884d52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Topotecan
135 rdf:type schema:DefinedTerm
136 N66a37d9ae6194e4992813c8b1d9119dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Deoxycytidine Kinase
138 rdf:type schema:DefinedTerm
139 N719cf776d6e04579aa97f6c57f49a7d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Proto-Oncogene Proteins c-akt
141 rdf:type schema:DefinedTerm
142 N740d0f752142419cadcf953f08076a76 schema:name nlm_unique_id
143 schema:value 0370635
144 rdf:type schema:PropertyValue
145 N7f898e8d80c144e691fc56b4bf45284b schema:volumeNumber 92
146 rdf:type schema:PublicationVolume
147 N81e20b57e297448eb71663e10db58042 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Phosphorylation
149 rdf:type schema:DefinedTerm
150 N87406a1519a24e8a82df562635fe8374 schema:name readcube_id
151 schema:value c8b2a0633725f3a8e00edd3d1d149046fa818c82961f5a97907499e0e70f1e55
152 rdf:type schema:PropertyValue
153 N8aee7fa99ffa47d48a418583f61103cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name DNA Fragmentation
155 rdf:type schema:DefinedTerm
156 Na2f3197a31074d8ab869a3e6e795118d rdf:first sg:person.01324114222.11
157 rdf:rest Nacee89609911497bb7cbc2e5b60253b8
158 Na88855a4b29b467496266ab69e75af83 rdf:first sg:person.0101712630.89
159 rdf:rest N5512702fc7004465a1bb3485f3448724
160 Naafbfee2b9f345c4b9e30e66a6a42918 schema:name dimensions_id
161 schema:value pub.1042132505
162 rdf:type schema:PropertyValue
163 Nacee89609911497bb7cbc2e5b60253b8 rdf:first sg:person.01003441425.29
164 rdf:rest rdf:nil
165 Nb1f05a7eaf024ba0a27f709c72e20f98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Protein-Serine-Threonine Kinases
167 rdf:type schema:DefinedTerm
168 Nb4d0fa1874614ee59dd9a9266a3cf12b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Antineoplastic Combined Chemotherapy Protocols
170 rdf:type schema:DefinedTerm
171 Nbd9af92e45a744a89094e99375fde543 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Cell Line, Tumor
173 rdf:type schema:DefinedTerm
174 Nbf0b162e14684dfb8c6cd30a4658b628 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Lung Neoplasms
176 rdf:type schema:DefinedTerm
177 Nc42a8558346c4a5899e77c1f88466f8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Humans
179 rdf:type schema:DefinedTerm
180 Nce632787b0c946c2ba4bda821ef101ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Deoxycytidine
182 rdf:type schema:DefinedTerm
183 Nd1ae83b105d14778bb8c40f482ce67aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Enzyme Inhibitors
185 rdf:type schema:DefinedTerm
186 Nd4d526f6cd4c4c1e9177f5a1451b1ee7 schema:name pubmed_id
187 schema:value 15700043
188 rdf:type schema:PropertyValue
189 Nd8c53ae8a9d54dac8862ac9d9ce19c21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Gene Expression Regulation, Neoplastic
191 rdf:type schema:DefinedTerm
192 Nda7f3b5a5c9043cb94d56f9675125750 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Topoisomerase I Inhibitors
194 rdf:type schema:DefinedTerm
195 Ndc9dc392eae24dcba1ced67daf2ca347 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Apoptosis
197 rdf:type schema:DefinedTerm
198 Ne2c11a5c98494926b5863e4e808e7616 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Proto-Oncogene Proteins
200 rdf:type schema:DefinedTerm
201 Ne65e3704e08e4beca6cdb681d2f1eb9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Caspase 3
203 rdf:type schema:DefinedTerm
204 Necd3324682c9475e944149cd7196e5a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Cell Cycle
206 rdf:type schema:DefinedTerm
207 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
208 schema:name Biological Sciences
209 rdf:type schema:DefinedTerm
210 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
211 schema:name Biochemistry and Cell Biology
212 rdf:type schema:DefinedTerm
213 sg:journal.1017082 schema:issn 0007-0920
214 1532-1827
215 schema:name British Journal of Cancer
216 rdf:type schema:Periodical
217 sg:person.01003441425.29 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
218 schema:familyName Mey
219 schema:givenName V
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003441425.29
221 rdf:type schema:Person
222 sg:person.0101712630.89 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
223 schema:familyName Del Tacca
224 schema:givenName M
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0101712630.89
226 rdf:type schema:Person
227 sg:person.01043347623.83 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
228 schema:familyName Basolo
229 schema:givenName F
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043347623.83
231 rdf:type schema:Person
232 sg:person.01324114222.11 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
233 schema:familyName Barachini
234 schema:givenName S
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324114222.11
236 rdf:type schema:Person
237 sg:person.0577505063.56 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
238 schema:familyName Giovannetti
239 schema:givenName E
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577505063.56
241 rdf:type schema:Person
242 sg:person.0704167507.01 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
243 schema:familyName Danesi
244 schema:givenName R
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704167507.01
246 rdf:type schema:Person
247 sg:pub.10.1007/s002800000183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000135772
248 https://doi.org/10.1007/s002800000183
249 rdf:type schema:CreativeWork
250 sg:pub.10.1007/s002800000273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031302839
251 https://doi.org/10.1007/s002800000273
252 rdf:type schema:CreativeWork
253 sg:pub.10.1023/a:1006325929424 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022329366
254 https://doi.org/10.1023/a:1006325929424
255 rdf:type schema:CreativeWork
256 sg:pub.10.1038/sj.bjc.6690452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004051184
257 https://doi.org/10.1038/sj.bjc.6690452
258 rdf:type schema:CreativeWork
259 sg:pub.10.1038/sj.cdd.4400336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042512023
260 https://doi.org/10.1038/sj.cdd.4400336
261 rdf:type schema:CreativeWork
262 sg:pub.10.2165/00003495-199754030-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011803547
263 https://doi.org/10.2165/00003495-199754030-00009
264 rdf:type schema:CreativeWork
265 https://app.dimensions.ai/details/publication/pub.1074273055 schema:CreativeWork
266 https://app.dimensions.ai/details/publication/pub.1074520995 schema:CreativeWork
267 https://app.dimensions.ai/details/publication/pub.1074708162 schema:CreativeWork
268 https://app.dimensions.ai/details/publication/pub.1074712924 schema:CreativeWork
269 https://app.dimensions.ai/details/publication/pub.1074778809 schema:CreativeWork
270 https://app.dimensions.ai/details/publication/pub.1074859791 schema:CreativeWork
271 https://app.dimensions.ai/details/publication/pub.1075104035 schema:CreativeWork
272 https://app.dimensions.ai/details/publication/pub.1082401402 schema:CreativeWork
273 https://app.dimensions.ai/details/publication/pub.1082893566 schema:CreativeWork
274 https://app.dimensions.ai/details/publication/pub.1083077109 schema:CreativeWork
275 https://app.dimensions.ai/details/publication/pub.1083269732 schema:CreativeWork
276 https://app.dimensions.ai/details/publication/pub.1083347691 schema:CreativeWork
277 https://doi.org/10.1002/(sici)1097-0215(20000515)86:4<570::aid-ijc20>3.0.co;2-t schema:sameAs https://app.dimensions.ai/details/publication/pub.1018134417
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1002/cncr.10806 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014472277
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1002/ijc.10166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015732358
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1016/s0006-2952(98)00316-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028767356
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1016/s0006-2952(98)00318-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018647627
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1016/s0092-8674(00)81005-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021076197
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1016/s0169-5002(02)00502-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018310648
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1016/s0169-5002(03)00136-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052265808
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1016/s0169-5002(03)90522-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016902652
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1016/s0304-4165(99)00209-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045475119
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1016/s0959-8049(98)00425-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032352964
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1016/s0959-8049(99)00223-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035253746
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1016/s1368-7646(02)00002-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039632637
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1021/bi9729357 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055215192
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1056/nejmoa031644 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018253348
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1074/jbc.274.7.4335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016160331
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1081/cnv-120022363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037383721
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1093/ajhp/54.2.162 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083077109
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1093/jnci/86.20.1517 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007437694
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1093/jnci/88.11.734 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046560733
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1136/bmj.311.7010.899 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062773493
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1158/0008-5472.can-03-3363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022118795
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1158/1078-0432.ccr-03-0520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036865675
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1159/000011923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013350898
324 rdf:type schema:CreativeWork
325 https://doi.org/10.3727/096504001108747819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074951474
326 rdf:type schema:CreativeWork
327 https://www.grid.ac/institutes/grid.5395.a schema:alternateName University of Pisa
328 schema:name Division of Pathological Anatomy and Histology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy
329 Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, 55, Via Roma, 56126 Pisa, Italy
330 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...